INS and neoplasm: Given that insulin is a known mitogen that regulates protein synthesis and neoplasia, enhance plasma insulin binds to and activates insulin receptors/insulin-like growth factor-1 receptors and the downstream insulin receptor substrate/phosphatidylinositide 3-kinases axis, promoting peripheral tissue growth and weight gain36–38.